Page last updated: 2024-11-10
3-sulfinopropionic acid
Description
3-sulfinopropionic acid: RN given refers to di-Na salt & not in Chemline 8/4/83; RN for parent cpd not in Chemline 8/4/83 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
3-sulfinopropionic acid : A monocarboxylic acid that is propionic acid in which one of the methyl hydrogens is replaced by a sulfino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 3016737 |
| CHEBI ID | 79222 |
| SCHEMBL ID | 13736202 |
| MeSH ID | M0053968 |
Synonyms (12)
| Synonym |
|---|
| 3-sulfinopropionic acid |
| AKOS006377452 |
| 3-sulfinopropanoic acid |
| 52329-65-4 |
| propanoic acid, 3-sulfino-, disodium salt |
| 77711-05-8 |
| propanoic acid, 3-sulfino- |
| CHEBI:79222 |
| SCHEMBL13736202 |
| DTXSID30200354 |
| Q27148274 |
| 3-sulfinopropanoicacid |
Drug Classes (2)
| Class | Description |
|---|
| monocarboxylic acid | An oxoacid containing a single carboxy group. |
| organosulfinic acid | Organic derivatives of sulfinic acid in which the sulfino group is linked directly to carbon. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.52
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.52 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.46 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |